353 related articles for article (PubMed ID: 24572582)
1. Increase in mortality rate in patients with dementia treated with atypical antipsychotics: a cohort study in outpatients in Central Italy.
Piersanti M; Capannolo M; Turchetti M; Serroni N; De Berardis D; Evangelista P; Costantini P; Orsini A; Rossi A; Maggio R
Riv Psichiatr; 2014; 49(1):34-40. PubMed ID: 24572582
[TBL] [Abstract][Full Text] [Related]
2. Profile of atypical-antipsychotics use in patients affected by dementia in the University Hospital of Ferrara.
Chiabrando G; Bianchi S; Poluzzi E; Montanaro N; Scanavacca P
Eur J Clin Pharmacol; 2010 Jul; 66(7):661-9. PubMed ID: 20464383
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm.
Maust DT; Kim HM; Seyfried LS; Chiang C; Kavanagh J; Schneider LS; Kales HC
JAMA Psychiatry; 2015 May; 72(5):438-45. PubMed ID: 25786075
[TBL] [Abstract][Full Text] [Related]
4. Comparison of incidence rates of cerebrovascular accidents and transient ischaemic attacks in observational cohort studies of patients prescribed risperidone, quetiapine or olanzapine in general practice in England including patients with dementia.
Layton D; Harris S; Wilton LV; Shakir SA
J Psychopharmacol; 2005 Sep; 19(5):473-82. PubMed ID: 16166184
[TBL] [Abstract][Full Text] [Related]
5. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics.
Finkel S; Kozma C; Long S; Greenspan A; Mahmoud R; Baser O; Engelhart L
Int Psychogeriatr; 2005 Dec; 17(4):617-29. PubMed ID: 16202186
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioural problems in persons with dementia.
Yury CA; Fisher JE
Psychother Psychosom; 2007; 76(4):213-8. PubMed ID: 17570959
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotic use and parkinsonism in dementia: effects of drug, dose, and sex.
Marras C; Herrmann N; Anderson GM; Fischer HD; Wang X; Rochon PA
Am J Geriatr Pharmacother; 2012 Dec; 10(6):381-9. PubMed ID: 23217531
[TBL] [Abstract][Full Text] [Related]
9. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and nonantipsychotic users.
Barnett MJ; Wehring H; Perry PJ
J Clin Psychopharmacol; 2007 Dec; 27(6):595-601. PubMed ID: 18004126
[TBL] [Abstract][Full Text] [Related]
10. Are all commonly prescribed antipsychotics associated with greater mortality in elderly male veterans with dementia?
Rossom RC; Rector TS; Lederle FA; Dysken MW
J Am Geriatr Soc; 2010 Jun; 58(6):1027-34. PubMed ID: 20487081
[TBL] [Abstract][Full Text] [Related]
11. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
13. Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.
Vigen CL; Mack WJ; Keefe RS; Sano M; Sultzer DL; Stroup TS; Dagerman KS; Hsiao JK; Lebowitz BD; Lyketsos CG; Tariot PN; Zheng L; Schneider LS
Am J Psychiatry; 2011 Aug; 168(8):831-9. PubMed ID: 21572163
[TBL] [Abstract][Full Text] [Related]
14. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
15. Risk of mortality among individual antipsychotics in patients with dementia.
Kales HC; Kim HM; Zivin K; Valenstein M; Seyfried LS; Chiang C; Cunningham F; Schneider LS; Blow FC
Am J Psychiatry; 2012 Jan; 169(1):71-9. PubMed ID: 22193526
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics and mortality in Parkinsonism.
Marras C; Gruneir A; Wang X; Fischer H; Gill SS; Herrmann N; Anderson GM; Hyson C; Rochon PA
Am J Geriatr Psychiatry; 2012 Feb; 20(2):149-58. PubMed ID: 22273735
[TBL] [Abstract][Full Text] [Related]
17. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Förstl H
Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
[No Abstract] [Full Text] [Related]
18. Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials.
Schneider LS; Dagerman K; Insel PS
Am J Geriatr Psychiatry; 2006 Mar; 14(3):191-210. PubMed ID: 16505124
[TBL] [Abstract][Full Text] [Related]
19. Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder.
Bhalerao S; Seyfried LS; Kim HM; Chiang C; Kavanagh J; Kales HC
J Geriatr Psychiatry Neurol; 2012 Mar; 25(1):29-36. PubMed ID: 22467844
[TBL] [Abstract][Full Text] [Related]
20. Mortality in patients with dementia treated with atypical antipsychotics (olanzapine, quetiapine and ziprasidone).
Martínez Martínez L; Olivera Fernández MR; Piñeiro Corrales G
Farm Hosp; 2009; 33(4):224-8. PubMed ID: 19712611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
